Skip to main content
Delfa

Lead sponsor

Actinogen Medical

3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.

3

Trials led

1

Ongoing

539

Total enrollment

65

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1/2
1
Phase 2
1
Phase 2/3
1

Trials by status

Active, not recruiting
1
Completed
2

Trials led

TrialEligibility highlightPhaseStatusEnrollment
XanaMIAAlzheimer's diseasePh 2/3Active, not recruiting247
XanADuAlzheimer's diseasePh 2Completed185
XanaMIA-DRAge 50-80Ph 1/2Completed107